International Stem Cell Corporation
ISCO
$0.18
$0.001.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.17% | 10.12% | 10.56% | 16.00% | 16.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.17% | 10.12% | 10.56% | 16.00% | 16.64% |
| Cost of Revenue | 7.15% | 8.80% | 12.75% | 19.27% | 18.33% |
| Gross Profit | -4.77% | 11.10% | 9.02% | 13.69% | 15.47% |
| SG&A Expenses | 1.29% | -3.82% | -3.55% | -5.65% | -1.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.34% | 2.46% | 4.69% | 5.94% | 8.29% |
| Operating Income | -292.65% | 117.86% | 84.18% | 87.54% | 89.74% |
| Income Before Tax | -100.00% | 91.30% | 64.77% | 19.29% | -59.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -100.00% | 91.30% | 64.77% | 19.29% | -59.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.00% | 91.30% | 64.77% | 19.29% | -59.54% |
| EBIT | -292.65% | 117.86% | 84.18% | 87.54% | 89.74% |
| EBITDA | -134.78% | 192.13% | 136.24% | 116.44% | 129.42% |
| EPS Basic | -91.27% | 74.34% | 48.43% | 20.78% | -27.20% |
| Normalized Basic EPS | -100.00% | 91.51% | 64.79% | 74.24% | 73.75% |
| EPS Diluted | -68.88% | 75.81% | 42.43% | 11.73% | -44.06% |
| Normalized Diluted EPS | -100.61% | 91.32% | 64.79% | 74.24% | 73.75% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.51% | 0.51% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |